16714-0679
                        
                    
                            Sunitinib malate
                        
                    
                                    Sunitinib malate
                                
                            
                        
                    
                            CAPSULE
                        
                    
                                    Oral
                                
                            
                        
                    
                                     SUNITINIB MALATE
                                
                                
                                     50.0
                                
                                
                                     mg/1
                                
                                
                            
                        
                    
                                     16714-0679-01
                                
                                
                                     28 CAPSULE in 1 BOTTLE (16714-679-01)
                                
                                
                                     Feb. 18, 2022
                                
                                
                                    Chemotherapy
                                
                            
                        
                    
                                    Tyrosine Kinase Inhibitor
                                
                            
                        
                    
                                    VEGFR, FLT, PDGFR, KIT, RET, CSF
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    